V

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Director International Business Analytics

Business AnalysisPosted on Nov 9
Full-timeRemote in UKNo salary listed

About the Job

Requirements

  • A bachelor's degree and 12 or more years of commercial biotechnology or pharmaceutical experience, with a track record of career progression and deep subject-matter expertise in commercial effectiveness and planning.
  • A proven track record of understanding, tracking, and challenging performance and launch strategies for specialty or rare-disease products, ideally in ophthalmology or endocrinology and in highly competitive, complex markets.
  • Demonstrated strategic thinking, collaboration, and tactical plan execution.
  • Strong analytical skills, including the ability to identify and interpret complex issues and provide appropriate recommendations to senior management and across functional areas.
  • Ability to collect, synthesize, and present data to leadership and across the organization.
  • Strong planning, organizing, and management skills, with the ability to excel in a dynamic, lean, scaling environment.
  • Interpersonal communication and presentation skills, including the ability to lead and influence cross-functionally and interface with other parts of the organization.
  • Ability to develop and maintain relationships with internal and external partners.
  • A proactive continuous-improvement mindset.
  • Commitment to ethical standards.
  • Willingness to travel internationally as required, approximately 20% of the time.

Responsibilities

  • Conduct in-depth market analysis to identify trends, opportunities, and potential risks, and provide actionable insights to support regional strategies, country-specific plans, strategic planning, and decision-making.
  • Work with US/Global forecasting to implement comprehensive forecasting models for current and future product lines and produce accurate revenue and market projections.
  • Lead primary and secondary research to gather stakeholder insights about attitudes, beliefs, and behaviors across the portfolio.
  • Present complex market insights and forecast data clearly to leadership and stakeholders across the organization.
  • Identify opportunities, risks, and implications in the competitive landscape, with a forward-looking focus on competitor events, activities, and major congresses, and provide strategic recommendations.
  • Inform development of target product profiles and forecasts for International projections for the future pipeline.
  • Build an internal operating model for harnessing customer relationship management insights, analytics delivery, and data management.
  • Generate insights into commercial-strategy effectiveness and recommend strategic and tactical shifts to optimize the impact of commercial investments.
  • Identify opportunities to adopt innovation, tools, and technologies to gain insights, differentiate, and maintain a competitive advantage.
  • Collaborate with cross-functional teams to understand internal customer needs and align forecasting, analytics, competitive intelligence, and market-insight plans with overall business strategies.
  • Partner with US/Global Commercial Effectiveness & Planning, including Market Research, Analytics, Forecasting, and Competitive Intelligence, as well as International Commercial, International Medical Affairs, and International Market Access.
  • Establish planning and tracking to ensure high-quality, on-time delivery of launch milestones within budget and on strategy.
  • Provide regular updates to the Vice President and Head of International on strategy, risks, and progress.

Desired Qualifications

  • Experience with specialty or rare-disease products, ideally in ophthalmology or endocrinology and in highly competitive, complex markets.

About the Company

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Viridian Therapeutics discovers and develops therapies that target microRNA (miRNA) pathways to treat autoimmune diseases, with a focus on thyroid eye disease. The company uses monoclonal antibody technology aimed at the IGF-1 receptor (IGF-1R) pathway to modulate disease biology. Its product approach integrates miRNA biology with antibody engineering to create treatments that intervene in autoimmune processes. The company differentiates itself by combining miRNA-targeting strategies with IGF-1R–focused monoclonal antibodies, operating in the clinical-stage space and concentrating on rare thyroid-related autoimmune conditions. Its goal is to advance clinical candidates through development toward regulatory approval and eventual market launch for patients who suffer from these diseases.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Viridian Therapeutics

See more jobs